The temporal impact of aging on the burden of herpes zoster

por Varghese, Lijoy, Standaert, Baudouin, Olivieri, Antonio, Curran, Desmond
Publicado 2017

Response to Wu et al. — Cost-effectiveness analysis of infant pneumococcal vaccination in Malaysia and Hong Kong

por Varghese, Lijoy, Mungall, Bruce, Zhang, Xu-Hao, Hoet, Bernard
Publicado 2016

Comment on: ‘Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada’, Wilson et al., 22 June 2018

por McGirr, Ashleigh, Iqbal, Shehzad M., Olbrecht, Jan, Varghese, Lijoy
Publicado 2018

A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjuga...

por Varghese, Lijoy, Talbot, Louise, Govender, Andrea, Zhang, Xu-Hao, Mungall, Bruce A.
Publicado 2018

The Potential Public Health Impact of Herpes Zoster Vaccination of People Aged ≥ 50 Years in Japan: Results of a Markov Model Analysis

por Watanabe, Daisuke, Mizukami, Akiko, Holl, Katsiaryna, Curran, Desmond, Van Oorschot, Desirée, Varghese, Lijoy, Shiragami, Makoto
Publicado 2018

How to assess for the full economic value of vaccines? From past to present, drawing lessons for the future

por Standaert, Baudouin, Sauboin, Christophe, DeAntonio, Rodrigo, Marijam, Alen, Gomez, Jorge, Varghese, Lijoy, Zhang, Sharon
Publicado 2020

Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea

por Kim, Yun-Kyung, Song, Joon Young, Jang, Hyeongap, Kim, Tae Hyun, Koo, Heejo, Varghese, Lijoy, Han, Euna
Publicado 2018

Assessment of the potential public health impact of Herpes Zoster vaccination in Germany

por Curran, Desmond, Van Oorschot, Desirée, Varghese, Lijoy, Oostvogels, Lidia, Mrkvan, Tomas, Colindres, Romulo, von Krempelhuber, Alfred, Anastassopoulou, Anastassia
Publicado 2017

Cost-effectiveness of the recombinant zoster vaccine in the German population aged ≥60 years old

por Van Oorschot, Desirée, Anastassopoulou, Anastassia, Poulsen Nautrup, Barbara, Varghese, Lijoy, von Krempelhuber, Alfred, Neine, Mohamed, Lorenc, Stéphane, Curran, Desmond
Publicado 2018

Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults

por McGirr, Ashleigh, Van Oorschot, Desiree, Widenmaier, Robyn, Stokes, Michael, Ganz, Michael L., Jung, Hyosung, Varghese, Lijoy, Curran, Desmond
Publicado 2019